The effect of N6-methyladenosine (m6A) factors on the development of acute respiratory distress syndrome in the mouse model

References

• Bellani G, Laffey JG, Pham T, et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. Jama. 2016;315(8):788–800.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Sakr Y, Ranieri VM. Epidemiology and outcome of acute respiratory failure in intensive care unit patients. Crit Care Med. 2003;31(Supplement):S296–9.
   PubMed Web of Science ®Google Scholar
• Katzenstein AL, Bloor CM, Leibow AA. Diffuse alveolar damage–the role of oxygen, shock, and related factors. A review. Am J Pathol. 1976;85:209–228.
   PubMed Web of Science ®Google Scholar
• Tomashefski JF Jr. Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med. 2000;21(3):435–466.
   PubMed Web of Science ®Google Scholar
• Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. Jama. 2012;307(23):2526–2533.
   PubMed Web of Science ®Google Scholar
• Metwaly S, Cote A, Donnelly SJ, et al. Evolution of ARDS biomarkers: will metabolomics be the answer? American Journal of Physiology. Lung Cellular and Molecular Physiology. 2018;315(4):L526–l34.
   PubMed Web of Science ®Google Scholar
• Dushianthan A, Cusack R, Goss V, et al. Clinical review: exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome–where do we go from here? Crit Care. 2012;16:238.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. J Integr Med. 2020;382(18):1708–1720.
   Google Scholar
• Brower RG, Matthay MA, Morris A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–1308.
   PubMed Web of Science ®Google Scholar
• Guérin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159–2168.
   PubMed Web of Science ®Google Scholar
• Cabrera-Benítez NE, Parotto M, Post M, et al. Mechanical stress induces lung fibrosis by epithelial-mesenchymal transition. Crit Care Med. 2012;40(2):510–517.
   PubMed Web of Science ®Google Scholar
• Zhang R, Pan Y, Fanelli V, et al. Mechanical Stress and the Induction of Lung Fibrosis via the Midkine Signaling Pathway. Am J Respir Crit Care Med. 2015;192(3):315–323.
   PubMed Web of Science ®Google Scholar
• Williams GW, Berg NK, Reskallah A, et al. Acute Respiratory Distress Syndrome. Anesthesiology. 2021;134(2):270–282.
   PubMed Web of Science ®Google Scholar
• Fang Q, Wang Q, Zhou Z, et al. Consensus analysis via weighted gene co-expression network analysis (WGCNA) reveals genes participating in early phase of acute respiratory distress syndrome (ARDS) induced by sepsis. Bioengineered. 2021;12(1):1161–1172.
   PubMed Web of Science ®Google Scholar
• Ma J, Li Q, Ji D, et al. Predicting candidate therapeutic drugs for sepsis-induced acute respiratory distress syndrome based on transcriptome profiling. Bioengineered. 2021;12(1):1369–1380.
   PubMed Web of Science ®Google Scholar
• El Gazzar M, Yoza BK, Hu JY, et al. Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance. J Biol Chem. 2007;282(37):26857–26864.
   PubMed Web of Science ®Google Scholar
• Szilágyi KL, Liu C, Zhang X, et al. Epigenetic contribution of the myosin light chain kinase gene to the risk for acute respiratory distress syndrome. Transl Res. 2017;180:12–21.
   PubMed Web of Science ®Google Scholar
• Maity A, Das B. N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases. The FEBS Journal. 2016;283(9):1607–1630.
   PubMed Web of Science ®Google Scholar
• Xiao K, Liu P, Yan P, et al. N6-methyladenosine reader YTH N6-methyladenosine RNA binding protein 3 or insulin like growth factor 2 mRNA binding protein 2 knockdown protects human bronchial epithelial cells from hypoxia/reoxygenation injury by inactivating p38 MAPK, AKT, ERK1/2, and NF-κB pathways. 2021.
   Google Scholar
• Bangaoil R, Santillan A, Angeles LM, et al. ATR-FTIR spectroscopy as adjunct method to the microscopic examination of hematoxylin and eosin-stained tissues in diagnosing lung cancer. PloS one. 2020;15(5):e0233626.
   PubMed Web of Science ®Google Scholar
• Nakajima N, Van Tin N, Sato Y, et al. Pathological study of archival lung tissues from five fatal cases of avian H5N1 influenza in Vietnam. Mod Pathol. 2013;26(3):357–369.
   PubMed Web of Science ®Google Scholar
• Chang JS, Lin ZX, Liu YJ, et al. Ultra performance liquid chromatography-tandem mass spectrometry assay for the quantification of RNA and DNA methylation. J Pharm Biomed Anal. 2021;197:113969.
   PubMed Web of Science ®Google Scholar
• Punsawad C, Viriyavejakul P, Techarang T. Surfactant Protein D Is Altered in Experimental Malaria-Associated Acute Lung Injury/Acute Respiratory Distress Syndrome. J Trop Med. 2019;2019:9281605.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu M, Yue P, et al. Novel Insights Into the Potential Mechanisms of N6-Methyladenosine RNA Modification on Sepsis-Induced Cardiovascular Dysfunction: an Update Summary on Direct and Indirect Evidences. Front Cell Dev Biol. 2021;9:772921.
   PubMed Web of Science ®Google Scholar
• Han YC, Xie HZ, Lu B, et al. Lipopolysaccharide Alters the m6A Epitranscriptomic Tagging of RNAs in Cardiac Tissue. Front Mol Biosci. 2021;8:670160.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhao BS, Roundtree IA, et al. N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency. Cell. 2015;161(6):1388–1399.
   PubMed Web of Science ®Google Scholar
• Shi Y, Fan S, Wu M, et al. YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression. Nature Communications. 2019;10(1):4892.
   PubMed Web of Science ®Google Scholar
• Roundtree IA, Luo GZ, Zhang Z, et al. YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs. Elif. 2017;6(6) :e31311.
   Web of Science ®Google Scholar
• Di Timoteo G, Dattilo D, Centrón-Broco A, et al. Modulation of circRNA Metabolism by m(6)A Modification. Cell Rep. 2020;31(6):107641.
   PubMed Web of Science ®Google Scholar
• Ahasic AM, Zhai R, Su L, et al. IGF1 and IGFBP3 in acute respiratory distress syndrome. Eur J Endocrinol. 2012;166(1):121–129.
   PubMed Web of Science ®Google Scholar
• Schnapp LM, Donohoe S, Chen J, et al. Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury. Am J Pathol. 2006;169(1):86–95.
   PubMed Web of Science ®Google Scholar
• Wang X, Lu Z, Gomez A, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505(7481):117–120.
   PubMed Web of Science ®Google Scholar
• Huang X, Lv D, Yang X, et al. m6A RNA methylation regulators could contribute to the occurrence of chronic obstructive pulmonary disease. J Cell Mol Med. 2020;24(21):12706–12715.
   PubMed Web of Science ®Google Scholar
• Huang S, Feng C, Chen L, et al. Identification of Potential Key Long Non-Coding RNAs and Target Genes Associated with Pneumonia Using Long Non-Coding RNA Sequencing (lncRNA-Seq): a Preliminary Study. Med Sci Monit. 2016;22:3394–3408.
   PubMed Web of Science ®Google Scholar
• Shi H, Wei J, He C. Where, When, and How: context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers. Mol Cell. 2019;74(4):640–650.
   PubMed Web of Science ®Google Scholar
• Feng Q, Zhao H, Xu L, et al. N6-Methyladenosine Modification and Its Regulation of Respiratory Viruses. Front Cell Dev Biol. 2021;9:699997.
   PubMed Web of Science ®Google Scholar
• Yu Y, Pan Y, Fan Z, et al. LuHui Derivative, A Novel Compound That Inhibits the Fat Mass and Obesity-Associated (FTO), Alleviates the Inflammatory Response and Injury in Hyperlipidemia-Induced Cardiomyopathy. Front Cell Dev Biol. 2021;9:731365.
   PubMed Web of Science ®Google Scholar
• Dang H, Polineni D, Pace RG, et al. Mining GWAS and eQTL data for CF lung disease modifiers by gene expression imputation. PloS one. 2020;15(11):e0239189.
   PubMed Web of Science ®Google Scholar
• Tan S, Li Z, Li K, et al. The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers. Front Cell Dev Biol. 2021;9:741521.
   PubMed Web of Science ®Google Scholar
• Kretschmer J, Rao H, Hackert P, et al. The m6A reader protein YTHDC2 interacts with the small ribosomal subunit and the 5′–3′ exoribonuclease XRN1. RNA. 2018;24(10):1339–1350.
   PubMed Web of Science ®Google Scholar
• Wang T, Kong S, Tao M, et al. The potential role of RNA N6-methyladenosine in Cancer progression. Mol Cancer. 2020;19(1):88.
   PubMed Web of Science ®Google Scholar
• Shi H, Zhao J, Han L, et al. Retrospective study of gene signatures and prognostic value of m6A regulatory factor in non-small cell lung cancer using TCGA database and the verification of FTO. Aging (Albany NY). 2020;12(17):17022–17037.
   PubMedGoogle Scholar
• Ding Y, Qi N, Wang K, et al. FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation. OncoTargets and Therapy. 2020;13:1461–1470.
   PubMed Web of Science ®Google Scholar
• Schwartz S, Mumbach MR, Jovanovic M, et al. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5’ sites. Cell Rep. 2014;8(1):284–296.
   PubMed Web of Science ®Google Scholar
• Bokar JA, Shambaugh ME, Polayes D, et al. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase. RNA. 1997;3:1233–1247.
   PubMed Web of Science ®Google Scholar
• Ping XL, Sun BF, Wang L, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24(2):177–189.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Y, Toth JI, et al. N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells. Nat Cell Biol. 2014;16(2):191–198.
   PubMed Web of Science ®Google Scholar
• Moindrot B, Cerase A, Coker H, et al. A Pooled shRNA Screen Identifies Rbm15, Spen, and Wtap as Factors Required for Xist RNA-Mediated Silencing. Cell Rep. 2015;12(4):562–572.
   PubMed Web of Science ®Google Scholar
• Meng Y, Zhang Q, Wang K, et al. RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes. Cell Death Dis. 2021;12(8):732.
   PubMed Web of Science ®Google Scholar
• Li C, Wang W, Xie SS, et al. The Programmed Cell Death of Macrophages, Endothelial Cells, and Tubular Epithelial Cells in Sepsis-AKI. Front Med (Lausanne). 2021;8:796724.
   PubMed Web of Science ®Google Scholar
• Evans KV, Lee JH. Alveolar wars: the rise of in vitro models to understand human lung alveolar maintenance, regeneration, and disease. Stem Cells Translational Medicine. 2020;9(8):867–881.
   PubMed Web of Science ®Google Scholar
• Paxson JA, Parkin CD, Iyer LK, et al. Global gene expression patterns in the post-pneumonectomy lung of adult mice. Respir Res. 2009;10(1):92.
   PubMed Web of Science ®Google Scholar